Table 2.
Variable | Total sample – n (%) |
Adherence club – n (%) |
Primary care clinic – n (%) |
p-value |
---|---|---|---|---|
Composite endpoint: Evidence of maternal retention in HIV care AND VL < 50 copies/mL at 12 months postpartum | ||||
Number of women eligible for composite endpoint | 110 | 77 | 33 | |
N (%) achieving composite endpoint | 91 (83) | 65 (84) | 26 (79) | 0.583 |
Retention in care (in all participants retained at study visits with VL data available) | ||||
Number of women retained at study visits with VL data available | 110 | 77 | 33 | |
Evidence of engagement in HIV care at 12 months postpartum | 96 (87) | 69 (90) | 27 (82) | 0.349 |
Retention in care (in all participants enrolled) | ||||
Number of women enrolled | 129 | 84 | 45 | |
Evidence of engagement in HIV care at 12 months postpartum | 111 (86) | 74 (88) | 37 (82) | 0.426 |
Viral load (in all participants retained at study visits with VL data available) | ||||
Number of women retained at study visits with VL data available | 110 | 77 | 33 | |
VL < 50 copies/mL at 12 months postpartum | 91 (83) | 65 (84) | 26 (79) | 0.583 |
VL < 1000 copies/mL at 12 months postpartum | 97 (88) | 69 (90) | 28 (85) | 0.525 |
Infant care services | ||||
Number of women | 129 | 84 | 45 | |
Evidence of infant PCR test < 12 weeks of age | 123 (95) | 81 (96) | 42 (93) | 0.420 |
Number of women retained in the study with infant immunization records available | 106 | 75 | 31 | |
Evidence of birth immunizations | 104 (98) | 73 (97) | 31 (100) | 1.000 |
Evidence of 6 week immunizations | 99 (93) | 68 (91) | 31 (100) | 0.103 |
Evidence of 10 week immunizations | 97 (92) | 68 (91) | 29 (94) | 1.000 |
VL Viral load